1. Taiwan Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Hi-Clearance Inc.

Hi-Clearance Inc.

TTPEX:1788
127.00
TWD
0.00
(0.00%)
8.80EPS
14.77P/E
5.79BMarket Cap
Hi-Clearance Inc.
TPEX:1788
(Taipei Exchange)

Recent

price

127.00

P/E

ratio

14.77

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
TWD
68.17
70
67.06
74.62
75.8
77.15
79.76
83.32
87.54
90.21
93.39
94.04
116
89.62
91.48
96.09
99.03
Revenue per Share
4.7
4.66
5.26
6.17
6.19
6.11
5.84
7.07
6.89
6.84
8.63
8.9
9.06
8.01
8.08
8.28
8.8
Basic EPS, GAAP
4.24
4.04
-8.41
9.92
0.05
1.09
8.98
3.71
1.29
6.08
4.93
3.5
7.43
8.49
5.07
6.25
5.52
Free Cash Flow per Basic Share
3.15
3.37
3.45
3.94
4.93
4.93
4.93
4.93
5.94
6.01
5.88
6.72
7.02
7.17
7
7
- -
Dividend per Share
28.45
37.38
38.56
40.78
42.16
42.97
43.79
45.76
46.21
49.07
52.98
56.98
59.59
67.02
67.43
68.53
66.31
Book Value per Share
26.26
35.57
37.35
39.57
40.95
41.76
42.59
44.55
45
47.77
47.57
52.22
55.23
62.78
63.51
63.51
61.63
Tangible Book Value per Share
30
30
36
36
36
36
36
36
35
36
37
39
40
43
45
45
45
Basic Weighted Avg Shares
2,023
2,129
2,381
2,650
2,692
2,740
2,833
2,959
3,095
3,241
3,432
3,684
4,690
3,896
4,073
4,278
4,410
Sales/Revenue/Turnover
6.45
6.94
6.2
8.87
9.22
8.49
8.56
9.19
9.59
9.33
10.72
11.23
9.85
10.66
10.51
9.85
10.57
Operating Margin (%)
35
39
35
32
36
37
33
33
38
106
132
151
161
165
179
199
199
Depreciation Expense
140
142
187
219
220
217
208
251
243
246
317
349
366
348
360
369
392
Net Income, GAAP
17.94
18.87
16.66
19.95
19.27
18.12
20.01
16.81
21
20.48
19.02
19.06
18.95
19.88
20.96
19.18
19.27
Effective Tax Rate (%)
6.9
6.66
7.84
8.27
8.16
7.92
7.33
8.49
7.87
7.58
9.25
9.46
7.81
8.93
8.83
8.61
8.89
Profit Margin (%)
364
800
851
891
914
979
1,033
1,002
779
1,238
900
824
909
1,387
1,082
1,117
975
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
908
823
518
473
482
519
459
558
LT Debt
910
1,368
1,401
1,481
1,523
1,526
1,558
1,625
1,641
1,784
2,013
2,304
2,440
2,984
3,002
3,051
2,952
Total Equity
10.19
9.15
8.1
11.89
11.82
10.88
10.97
12.4
11.71
9.54
9.84
9.79
10.54
9.05
8.77
8.28
9.25
Return on Invested Capital (%)
14.18
11.39
12.35
14.03
13.51
12.75
12.01
13.99
12.55
10.5
10.81
10.73
10.88
10.06
9.74
9.47
10.22
Return on Capital (%)
16.55
12.93
13.84
15.55
14.92
14.35
13.47
15.79
14.91
14.35
16.71
16.15
15.45
12.83
12.02
12.18
13.48
Return on Common Equity (%)

Capital Structure

TWD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
599
660
604
LT Borrowings
- -
- -
- -
LT Finance Leases
459
562
558
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
45
45
45
Market Capitalization
6,077
6,077
5,788

Working Capital

TWD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
2,658
2,705
2,729
Cash, Cash Equivalents & STI
599
554
565
Accounts Receivable, Net
1,028
1,105
1,098
Inventories
745
781
771
Total Current Liabilities
1,541
1,519
1,754
Payables & Accruals
- -
- -
- -
ST Debt
599
660
604
Deferred Revenue
- -
- -
- -

Growth Rates

TWD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
7.38%
8.98%
1.63%
Free Cash Flow
106.63%
20.43%
23.45%
Net Income, GAAP
5.94%
3.15%
2.45%
Sales/Revenue/Turnover
5.03%
5.46%
5.04%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
965
1,097
1,009
1,002
4,073
2025
1,050
1,070
1,066
1,092
4,278
2026
1,145
1,108
- -
- -
- -

Quarterly Earnings Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2.16
2.45
1.85
1.62
8.08
2025
1.9
2.2
2.13
2.04
8.28
2026
2.34
2.29
- -
- -
- -

Quarterly Dividends Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
7
2025
- -
- -
- -
- -
7
2026
- -
- -
- -
- -
- -
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Hi-Clearance Inc. Hi-Clearance Inc. is a Taiwan-based company principally engaged in the distribution and sales of medical equipment, biochemical reagents and devices across renal, cardiac, radiation, dental, oral surgery and metabolism markets. The company offers dialyzers, dialysis and reverse osmosis machines, related consumables and drugs including blood tubings, puncture needles, physiological saline, sanitizing liquids, dialysis liquids and powders, and erythropoietin; interventional cardiology and radiology devices, vascular surgery products, and Inoue balloon catheters; dental consumables, implant materials and equipment; blood glucose monitors, related consumables and nutrition products; artificial dermises; and hemodialysis management services, as well as design and operation of dialysis centers. Hi-Clearance Inc. also sells and services healthy natural drinks and acts as an OEM supplier for beverage raw materials and concentrates. Founded in 1989 and headquartered in New Taipei City at 8F-2, No. 2, Lane 609, Sec. 5, Chongxin Rd., Sanchong Dist., the company primarily serves the Taiwan healthcare market with additional branches including Taichung, Tainan and Kaohsiung service centers.